Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Hans Biomed Corp. (042520)
Market Open
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
23,800.
00
+400
+1.7094%
₩
405.17B
Market Cap
-
P/E Ratio
240%
Div Yield
11,946
Volume
-
Eps
₩
23,400
Previous Close
Watching
Watch
Add Transaction
Day Range
23,200
24,100
Year Range
6,970
57,800
Want to track
042520
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Hans Biomed Corp. (042520) Statistics
Valuation metrics
Market Cap
405.17B
Enterprise value
428.98B
Trailing P/E (ttm)
-11.79
Forward P/E
15.93
PEG ratio
-0.04
Price/Sales (ttm)
3.67
Price/Book (mrq)
5.48
Enterprise Value/Revenue
3.88
Enterprise Value/EBITDA
-24.28
Overview
Shares outstanding
14.24M
Float
8.75M
Shares short
-
% Held by insiders
0.43%
% Held by institutions
0.09%
Average volume (10 days)
346.06K
Average volume (90 days)
343.75K
Price summary
52-Week low
6,970
52-Week high
57,800
Beta
1.86
50-Day moving average
32,399
200-Day moving average
29,266
Dividends and splits
Forward annual dividend rate
240
Forward annual dividend yield
0.0084%
Trailing annual dividend rate
240
Trailing annual dividend yield
0.0084%
5-Year annual dividend yield
0.5%
Payout ratio
-
Dividend Date
5 Oct 2020
Ex-Dividend Date
28 Sep 2020
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
30 Sep 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-0.22%
Operating margin
0.13%
Operational effectiveness
Return on assets
-0.1%
Return on equity
-0.37%
Income Statement
Revenue (ttm)
110.5B
Revenue per share (ttm)
8,303.87
Quarterly revenue growth (yoy)
0.43%
Gross profit (ttm)
65.37B
EBITDA
-17.67B
Net income to common (ttm)
-24.85B
Diluted EPS (ttm)
-2,413
Quarterly earnings growth (yoy)
3.76%
Balance Sheet
Total cash (mrq)
17.95B
Total cash per share (mrq)
1,259.14
Total debt (mrq)
42.23B
Total Debt/Equity (mrq)
57.08
Current ratio (mrq)
1.24%
Book value per share (mrq)
5,188.23
Cash Flow
Cash flow statement
-20.21B
Levered free cash flow (LFCF)
-16.1B